Extramammary Paget Disease Overview

Save information for later
Sign Up

Learn About Extramammary Paget Disease

What is the definition of Extramammary Paget Disease?
Extramammary Paget disease (EMPD) is characterized by a chronic eczema-like rash of the skin around the genital regions of males and females. Under the microscope, this condition looks very similar to a condition that occurs on the breast called mammary Paget disease. The primary difference between the two is the location of the rash. While the location of the rash for individuals with mammary Paget disease is around the nipple and areolar skin, EMPD may occur in the vulva, perianal region, scrotum, penis, and axilla. About 25 percent of Extramammary Paget disease is associated with an underlying cancer.
What are the alternative names for Extramammary Paget Disease?
  • Extramammary Paget disease
  • EMPD
  • Paget disease, extramammary
Who are the top Extramammary Paget Disease Local Doctors?
Taku Fujimura
Elite in Extramammary Paget Disease
Taku Fujimura
Elite in Extramammary Paget Disease
Taku Fujimura
Sendai, JP 

Taku Fujimura practices in Sendai, Japan. Mr. Fujimura is rated as an Elite expert by MediFind in the treatment of Extramammary Paget Disease. His top areas of expertise are Angiosarcoma, Extramammary Paget Disease, Melanoma, and Cutaneous T-Cell Lymphoma (CTCL).

Naoya Yamazaki
Elite in Extramammary Paget Disease
Naoya Yamazaki
Elite in Extramammary Paget Disease
Naoya Yamazaki
Tokyo, JP 

Naoya Yamazaki practices in Tokyo, Japan. Mr. Yamazaki is rated as an Elite expert by MediFind in the treatment of Extramammary Paget Disease. His top areas of expertise are Melanoma, Extramammary Paget Disease, Angiosarcoma of the Scalp, and Angiosarcoma.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Extramammary Paget Disease
Atsushi Otsuka
Elite in Extramammary Paget Disease
Atsushi Otsuka
Osaka, JP 

Atsushi Otsuka practices in Osaka, Japan. Mr. Otsuka is rated as an Elite expert by MediFind in the treatment of Extramammary Paget Disease. His top areas of expertise are Extramammary Paget Disease, Angiosarcoma, Atopic Dermatitis, Nephrectomy, and Prostatectomy.

View All Doctors
What are the latest Extramammary Paget Disease Clinical Trials?
A First-In-Human Phase I, Open Label, Safety and Tolerability Study of Escalating Multiple Doses of Intratumoral MQ710, a Multi-Transgene Expressing Modified Vaccinia Virus Ankara-Based Virotherapy, Alone and in Combination With the Systemic Checkpoint Inhibitor Pembrolizumab in Solid Tumors
A First-In-Human Phase I, Open Label, Safety and Tolerability Study of Escalating Multiple Doses of Intratumoral MQ710, a Multi-Transgene Expressing Modified Vaccinia Virus Ankara-Based Virotherapy, Alone and in Combination With the Systemic Checkpoint Inhibitor Pembrolizumab in Solid Tumors
Enrollment Status: Recruiting
Publish Date: December 03, 2025
Intervention Type: Biological, Drug
Study Phase: Phase 1

Summary: Participants of this study will have a diagnosis of a solid tumor cancer that has come back to its original location or spread beyond its original location (advanced), came back (relapsed) or worsened (refractory) after standard treatments, or no standard treatments are available for the participants' cancer. The purpose of this study if to find the highest dose of MQ710 that causes few or mild si...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Prospective Registry of Gynecologic Patients With Extramammary Paget's Disease
Prospective Registry of Gynecologic Patients With Extramammary Paget's Disease
Enrollment Status: Recruiting
Publish Date: August 29, 2025

Summary: In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of skin affected by EMPD, in order to better understand this condition.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center